TXNIP blocks autophagic flux, causes alpha-synuclein accumulation

TXNIP blocks autophagic flux, causes α-synuclein accumulation

(HealthDay)—Thioredoxin-interacting protein (TXNIP) blocks autophagic flux and induces expression of α-synuclein accumulation via inhibition of ATP13A2, according to a study published online July 29 in CNS Neuroscience & Therapeutics.

Cun-Jin Su, from the Hospital of Soochow University in Suzhou, China, and colleagues examined the effects of TXNIP on autophagic and α-synuclein accumulation by Western blot in HEK293 cells, which had been transfected with TXNIP plasmid.

The researchers found that TXNIP induced expression of LC3-II, but failed to degrade the autophagy substrate p62. TXNIP also aggravated accumulation of α-synuclein. TXNIP inhibited the of the lysosomal membrane protein ATP13A2; overexpression of ATP13A2 attenuated the TXNIP-linked impairment of autophagic flux and α-synuclein accumulation. In the substantia nigra, overexpression of TXNIP resulted in loss of dopaminergic neurons.

"Our data suggested that TXNIP blocked autophagic flux and induced α-synuclein accumulation through inhibition of ATP13A2, indicating TXNIP was a disease-causing in Parkinson's disease," the authors write.

Explore further

TXNIP may mediate insulin sensitivity in caloric restriction

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: TXNIP blocks autophagic flux, causes alpha-synuclein accumulation (2017, August 2) retrieved 31 March 2020 from https://medicalxpress.com/news/2017-08-txnip-blocks-autophagic-flux-alpha-synuclein.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments